BIOA

BioAge Labs, Inc. - Common Stock (BIOA)

About BioAge Labs, Inc. - Common Stock (BIOA)

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.

Details

Daily high

$8.10

Daily low

$7.73

Price at open

$8.07

52 Week High

$25.96

52 Week Low

$4.88

Market cap

369.9M

Dividend yield

Volume

787,316

Avg. volume

626,712

P/E ratio

-3.38

BioAge Labs, Inc. - Common Stock News